ArticleNPJ breast cancer2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.
Albert Grinshpun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it